Diagnostics News and Research

RSS

Study finds solution for debate about mutation testing to prevent children with cystic fibrosis

Testing for genetic mutations beyond those medically recommended is unlikely to prevent the birth of children with classic cystic fibrosis and may detect mutations causing only mild disease, according to a study published online in Genetics in Medicine, the official publication of the American College of Medical Genetics (ACMG).

From Quest Diagnostics 24 Nov 2010

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

24 Nov 2010

iPrEx oral PrEP study achieves major milestone in HIV prevention research

This is a great day in the fight against AIDS. The positive results of the iPrEx oral PrEP study are a major milestone in HIV prevention research and provide important information about how antiretroviral drugs might be used for prevention by HIV-negative people at high risk for HIV infection, said AVAC Executive Director Mitchell Warren.

24 Nov 2010

New genomic approach to evaluate suspicious thyroid nodules

Doctors at the University of Colorado School of Medicine were concerned recently when they found a nodule in the thyroid of a 64-year-old Colorado man. They extracted cells from the nodule, hoping to determine whether the man had cancer. But the biopsy results were inconclusive.

24 Nov 2010

Hologic announces receipt of FDA approvable letter for Selenia Dimensions 3-D digital mammography system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that Hologic has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system.

From Hologic, Inc. 23 Nov 2010

AADR Fall Focused Symposium highlights fast-moving field of Salivary Diagnostics

The American Association for Dental Research (AADR) held its 3rd Fall Focused Symposium on November 12-13, in the Washington, DC, area. This year, the theme was the fast-moving field of Salivary Diagnostics, with a focus on Scientific & Clinical Frontiers.

23 Nov 2010

Grant adds PTR-35 360° vertical rotator to bio product range

Grant Instruments, a world-renowned supplier of scientific, life sciences and data acquisition products, has introduced a variable speed, variable angle 360º vertical rotator combining three mixing functions - vertical rotation, reciprocation and vibration - into one easy-to-use and highly versatile compact unit.

23 Nov 2010

New simple diagnostic tool to detect dangerous viruses

Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.

22 Nov 2010

Spectral enters distribution agreement with Toray to market TORAYMYXIN in Canada

Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.

22 Nov 2010

OraSure granted FDA approval for final phase studies of OraQuick Rapid HIV-1/2 Antibody Test

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced that the U.S. Food and Drug Administration ("FDA") has granted an investigational device exemption (IDE) for the Company to conduct the final phase of clinical testing for FDA approval of its OraQuick® Rapid HIV-1/2 Antibody Test for sale in the consumer or over-the-counter ("OTC") market.

22 Nov 2010

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.

22 Nov 2010

People with heart disease, diabetes or cancer believe economic downturn hurts their health: Poll

A new poll from researchers at the Harvard School of Public Health and Knowledge Networks shows that many people with heart disease, diabetes or cancer believe the economic downturn is hurting their health and will have further negative impacts in the future. Many Americans with these illnesses face financial problems paying for medical bills in this economy.

20 Nov 2010

Ridge announces data from Clinical Experience Program on blood test for MDD disorder

Ridge Diagnostics, Inc., a neurodiagnostic company, announced that data from a Clinical Experience Program for its first-in-class, proprietary blood test for Major Depressive Disorder (MDD) will be presented during a poster session entitled Clinician Acceptance and Utility of a Multianalyte Biomarker Panel for Major Depressive Disorder (MDD) Diagnosis.

19 Nov 2010

HSR Act applicable to LabCorp’s acquisition of Genzyme

Laboratory Corporation of America Holdings today announced that it has received early termination from the Federal Trade Commission of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Genzyme Genetics, a business unit of Genzyme Corp. by LabCorp.

19 Nov 2010

Sekisui enters asset purchase agreement to acquire Genzyme's Diagnostic products

Genzyme Corporation today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme's Diagnostic products business for $265 million in cash.

19 Nov 2010

U-Systems initiates EASY study for screening breast cancer

U-Systems, the leader in Automated Breast Ultrasound technology announced participant enrollment has begun in the European Asymptomatic Screening Study (EASY) at Capio Saint Göran Hospital, in Stockholm, Sweden.

18 Nov 2010

New pharmacogenetic test enables a personalized medicine approach

Luminex Corporation, today announced that it has commercially launched its first pharmacogenetic test, the xTAG CYP2D6 Kit, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

From Luminex 17 Nov 2010

Imec and PEIRA develop platform for in-vitro study of brain tissue

The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.

17 Nov 2010

Innovative neural probe senses and stimulates individual brain cells

Imec, together with its partners within the European FP6 Program NeuroProbes, has created a new neural probe enabling electrical and chemical recording and stimulation of single neurons in the brain. Applications of the new technology are vast, ranging from tools for fundamental research on the functioning of the brain, to instruments for more precise diagnosis of brain seizures before brain-surgery.

17 Nov 2010

Health professionals invited for 1st Asia-Pacific Osteoporosis Meeting

Healthcare providers in the Asia-Pacific region are coping with a rising tide of osteoporotic fractures. The IOF Regionals - 1st Asia- Pacific Osteoporosis Meeting, to take place in Singapore from December 10-13, 2010, is an ideal opportunity for health professionals in the region to acquire the latest practical information on osteoporosis and related fractures.

17 Nov 2010

Diagnostics News and Research

Study finds solution for debate about mutation testing to prevent children with cystic fibrosis

Amorfix introduces high affinity antibodies against cancer primary cells

iPrEx oral PrEP study achieves major milestone in HIV prevention research

New genomic approach to evaluate suspicious thyroid nodules

Hologic announces receipt of FDA approvable letter for Selenia Dimensions 3-D digital mammography system

AADR Fall Focused Symposium highlights fast-moving field of Salivary Diagnostics

Grant adds PTR-35 360° vertical rotator to bio product range

New simple diagnostic tool to detect dangerous viruses

Spectral enters distribution agreement with Toray to market TORAYMYXIN in Canada

OraSure granted FDA approval for final phase studies of OraQuick Rapid HIV-1/2 Antibody Test

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

People with heart disease, diabetes or cancer believe economic downturn hurts their health: Poll

Ridge announces data from Clinical Experience Program on blood test for MDD disorder

HSR Act applicable to LabCorp’s acquisition of Genzyme

Sekisui enters asset purchase agreement to acquire Genzyme's Diagnostic products

U-Systems initiates EASY study for screening breast cancer

New pharmacogenetic test enables a personalized medicine approach

Imec and PEIRA develop platform for in-vitro study of brain tissue

Innovative neural probe senses and stimulates individual brain cells

Health professionals invited for 1st Asia-Pacific Osteoporosis Meeting

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News